comparemela.com
Home
Live Updates
NeuroSense Therapeutics & Massachusetts General Hospitals NeuroEpigenetics Lab to Collaborate on Elucidating Neurotherapeutic Effects of PrimeC in ALS : comparemela.com
NeuroSense Therapeutics & Massachusetts General Hospital's NeuroEpigenetics Lab to Collaborate on Elucidating Neurotherapeutic Effects of PrimeC in ALS
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
Related Keywords
Massachusetts ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Sweden ,
Boston ,
Gothenburg ,
Vastra Gotalands Lan ,
Shiran Zimri ,
Ghazaleh Sadri Vakili ,
Hospital Neuroepigenetics Lab ,
Professor At Harvard Medical School ,
Massgeneral Institute For Neurodegenerative Disease ,
Prnewswire Neurosense Therapeutics Ltd ,
Linkedin ,
Neurosense Therapeutics Ltd ,
Twitter ,
European Medicines Agency ,
Nasdaq ,
Drug Administration ,
Therapy Conference ,
Sense Therapeutics ,
Massachusetts General Hospital ,
Neuroepigenetics Lab ,
Associate Professor ,
Harvard Medical School ,
Massgeneral Institute ,
Neurodegenerative Disease ,
Vice President ,
Neuron Derived Exosomes ,
Orphan Drug Designation ,
Neurosense ,
comparemela.com © 2020. All Rights Reserved.